ID   PTPS_HUMAN              Reviewed;         145 AA.
AC   Q03393; B0YJ87; Q8WVG8;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1993, sequence version 1.
DT   18-JUN-2025, entry version 227.
DE   RecName: Full=6-pyruvoyl tetrahydrobiopterin synthase;
DE            Short=PTP synthase;
DE            Short=PTPS;
DE            EC=4.2.3.12;
GN   Name=PTS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND CATALYTIC ACTIVITY.
RC   TISSUE=Liver;
RX   PubMed=1282802; DOI=10.1016/0006-291x(92)90235-d;
RA   Thoeny B., Leimbacher W., Buergisser D., Heizmann C.W.;
RT   "Human 6-pyruvoyltetrahydropterin synthase: cDNA cloning and heterologous
RT   expression of the recombinant enzyme.";
RL   Biochem. Biophys. Res. Commun. 189:1437-1443(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8216273; DOI=10.1006/bbrc.1993.2197;
RA   Ashida A., Hatakeyama K., Kagamiyama H.;
RT   "cDNA cloning, expression in Escherichia coli and purification of human 6-
RT   pyruvoyl-tetrahydropterin synthase.";
RL   Biochem. Biophys. Res. Commun. 195:1386-1393(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT HPABH4A VAL-114.
RX   PubMed=7698774; DOI=10.1006/geno.1994.1642;
RA   Ashida A., Owada M., Hatakeyama K.;
RT   "A missense mutation (A to G) of 6-pyruvoyltetrahydropterin synthase in
RT   tetrahydrobiopterin-deficient form of hyperphenylalaninemia.";
RL   Genomics 24:408-410(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8841415; DOI=10.1111/j.1432-1033.1996.0477h.x;
RA   Kluge C., Brecevic L., Heizmann C.W., Blau N., Thoeny B.;
RT   "Chromosomal localization, genomic structure and characterization of the
RT   human gene and a retropseudogene for 6-pyruvoyltetrahydropterin synthase.";
RL   Eur. J. Biochem. 240:477-484(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Liu T.T., Lu S.F., Hsiao K.J.;
RT   "Genomic structure of 6-pyruvoyl-tetrahydropterin synthase gene and a T/C
RT   polymorphism detected in Chinese.";
RL   J. Biomed. Lab. Sci. 10:39-47(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Hsiao K.-J., Liu T.-T., Chang Y.-H., Chiu Y.-H., Chiang S.-H., Chang H.-M.,
RA   Chen C.-Y., Tsai S.-F.;
RT   "Isolation and sequencing of human 6-pyruvoyl-tetrahydropterin synthase
RT   gene containing BAC clone 321H15.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19 AND TYR-128, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   CHARACTERIZATION OF VARIANTS HPABH4A CYS-16 AND GLN-25, KINETIC PARAMETERS,
RP   PHOSPHORYLATION AT SER-19, AND MUTAGENESIS OF SER-19.
RX   PubMed=10531334; DOI=10.1074/jbc.274.44.31341;
RA   Scherer-Oppliger T., Leimbacher W., Blau N., Thoeny B.;
RT   "Serine 19 of human 6-pyruvoyltetrahydropterin synthase is phosphorylated
RT   by cGMP protein kinase II.";
RL   J. Biol. Chem. 274:31341-31348(1999).
RN   [15]
RP   REVIEW ON VARIANTS.
RX   PubMed=9222755;
RX   DOI=10.1002/(sici)1098-1004(1997)10:1<11::aid-humu2>3.0.co;2-p;
RA   Thoeny B., Blau N.;
RT   "Mutations in the GTP cyclohydrolase I and 6-pyruvoyl-tetrahydropterin
RT   synthase genes.";
RL   Hum. Mutat. 10:11-20(1997).
RN   [16]
RP   VARIANTS HPABH4A CYS-16 AND GLN-25.
RX   PubMed=8178819;
RA   Thoeny B., Leimbacher W., Blau N., Harvie A., Heizmann C.W.;
RT   "Hyperphenylalaninemia due to defects in tetrahydrobiopterin metabolism:
RT   molecular characterization of mutations in 6-pyruvoyl-tetrahydropterin
RT   synthase.";
RL   Am. J. Hum. Genet. 54:782-792(1994).
RN   [17]
RP   CHARACTERIZATION OF VARIANTS HPABH4A CYS-16; GLN-25; VAL-57 DEL AND LEU-87.
RX   PubMed=7493990; DOI=10.1074/jbc.270.49.29498;
RA   Oppliger T., Thoeny B., Nar H., Buergisser D., Huber R., Heizmann C.W.,
RA   Blau N.;
RT   "Structural and functional consequences of mutations in 6-
RT   pyruvoyltetrahydropterin synthase causing hyperphenylalaninemia in humans.
RT   Phosphorylation is a requirement for in vivo activity.";
RL   J. Biol. Chem. 270:29498-29506(1995).
RN   [18]
RP   VARIANTS HPABH4A SER-52 AND SER-87.
RX   PubMed=8707300; DOI=10.1007/s004390050213;
RA   Liu T.T., Hsiao K.J.;
RT   "Identification of a common 6-pyruvoyl-tetrahydropterin synthase mutation
RT   at codon 87 in Chinese phenylketonuria caused by tetrahydrobiopterin
RT   synthesis deficiency.";
RL   Hum. Genet. 98:313-316(1996).
RN   [19]
RP   VARIANTS HPABH4A VAL-57 DEL; MET-67; GLU-129 AND VAL-136.
RX   PubMed=9222757;
RX   DOI=10.1002/(sici)1098-1004(1997)10:1<25::aid-humu4>3.0.co;2-l;
RA   Oppliger T., Thoeny B., Kluge C., Matasovic A., Heizmann C.W., Ponzone A.,
RA   Spada M., Blau N.;
RT   "Identification of mutations causing 6-pyruvoyl-tetrahydropterin synthase
RT   deficiency in four Italian families.";
RL   Hum. Mutat. 10:25-35(1997).
RN   [20]
RP   VARIANT HPABH4A VAL-114.
RX   PubMed=9159737; DOI=10.1002/mds.870120321;
RA   Hanihara T., Inoue K., Kawanishi C., Sugiyama N., Miyakawa T., Onishi H.,
RA   Yamada Y., Osaka H., Kosaka K., Iwabuchi K., Owada M.;
RT   "6-pyruvoyl-tetrahydropterin synthase deficiency with generalized dystonia
RT   and diurnal fluctuation of symptoms: a clinical and molecular study.";
RL   Mov. Disord. 12:408-411(1997).
RN   [21]
RP   VARIANTS HPABH4A GLY-25; SER-52; MET-56; ASP-70; SER-87; ASN-96 AND
RP   MET-106.
RX   PubMed=9450907;
RX   DOI=10.1002/(sici)1098-1004(1998)11:1<76::aid-humu12>3.0.co;2-w;
RA   Liu T.-T., Hsiao K.-J., Lu S.-F., Wu S.-J., Wu K.-F., Chiang S.-H.,
RA   Liu X.-Q., Chen R.-G., Yu W.-M.;
RT   "Mutation analysis of the 6-pyruvoyl-tetrahydropterin synthase gene in
RT   Chinese hyperphenylalaninemia caused by tetrahydrobiopterin synthesis
RT   deficiency.";
RL   Hum. Mutat. 11:76-83(1998).
RN   [22]
RP   VARIANTS HPABH4A VAL-57 DEL AND MET-97.
RX   PubMed=10585341;
RA   Romstad A., Guldberg P., Blau N., Guettler F.;
RT   "Single-step mutation scanning of the 6-pyruvoyltetrahydropterin synthase
RT   gene in patients with hyperphenylalaninemia.";
RL   Clin. Chem. 45:2102-2108(1999).
RN   [23]
RP   VARIANTS HPABH4A ASP-47 AND GLY-116.
RX   PubMed=10220141;
RX   DOI=10.1002/(sici)1098-1004(1999)13:4<286::aid-humu4>3.0.co;2-c;
RA   Scherer-Oppliger T., Matasovic A., Laufs S., Levy H.L., Quackenbush E.J.,
RA   Blau N., Thoeny B.;
RT   "Dominant negative allele (N47D) in a compound heterozygote for a variant
RT   of 6-pyruvoyltetrahydropterin synthase deficiency causing transient
RT   hyperphenylalaninemia.";
RL   Hum. Mutat. 13:286-289(1999).
RN   [24]
RP   VARIANT HPABH4A CYS-99.
RX   PubMed=10874306;
RX   DOI=10.1002/1098-1004(200007)16:1<54::aid-humu10>3.0.co;2-c;
RA   Blau N., Scherer-Oppliger T., Baumer A., Riegel M., Matasovic A.,
RA   Schinzel A., Jaeken J., Thoeny B.;
RT   "Isolated central form of tetrahydrobiopterin deficiency associated with
RT   hemizygosity on chromosome 11q and a mutant allele of PTPS.";
RL   Hum. Mutat. 16:54-60(2000).
RN   [25]
RP   VARIANTS HPABH4A PHE-26; MET-67; LEU-87; LEU-124; GLY-136 AND VAL-136.
RX   PubMed=11388593; DOI=10.1007/s004310000722;
RA   Dudesek A., Roeschinger W., Muntau A.C., Seidel J., Leupold D., Thoeny B.,
RA   Blau N.;
RT   "Molecular analysis and long-term follow-up of patients with different
RT   forms of 6-pyruvoyl-tetrahydropterin synthase deficiency.";
RL   Eur. J. Pediatr. 160:267-276(2001).
CC   -!- FUNCTION: Involved in the biosynthesis of tetrahydrobiopterin, an
CC       essential cofactor of aromatic amino acid hydroxylases. Catalyzes the
CC       transformation of 7,8-dihydroneopterin triphosphate into 6-pyruvoyl
CC       tetrahydropterin. {ECO:0000269|PubMed:1282802}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=7,8-dihydroneopterin 3'-triphosphate = 6-pyruvoyl-5,6,7,8-
CC         tetrahydropterin + triphosphate + H(+); Xref=Rhea:RHEA:22048,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:18036, ChEBI:CHEBI:58462,
CC         ChEBI:CHEBI:136564; EC=4.2.3.12;
CC         Evidence={ECO:0000269|PubMed:1282802};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=8.1 uM for 7,8-dihydroneopterin triphosphate
CC         {ECO:0000269|PubMed:10531334};
CC         Vmax=120 nmol/min/mg enzyme {ECO:0000269|PubMed:10531334};
CC   -!- PATHWAY: Cofactor biosynthesis; tetrahydrobiopterin biosynthesis;
CC       tetrahydrobiopterin from 7,8-dihydroneopterin triphosphate: step 1/3.
CC   -!- SUBUNIT: Homohexamer formed of two homotrimers in a head to head
CC       fashion.
CC   -!- INTERACTION:
CC       Q03393; Q96CW1: AP2M1; NbExp=3; IntAct=EBI-712344, EBI-297683;
CC       Q03393; P38432: COIL; NbExp=3; IntAct=EBI-712344, EBI-945751;
CC       Q03393; Q96D03: DDIT4L; NbExp=3; IntAct=EBI-712344, EBI-742054;
CC       Q03393; P51116: FXR2; NbExp=4; IntAct=EBI-712344, EBI-740459;
CC       Q03393; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-712344, EBI-739832;
CC       Q03393; Q96HA8: NTAQ1; NbExp=3; IntAct=EBI-712344, EBI-741158;
CC       Q03393; Q03393: PTS; NbExp=16; IntAct=EBI-712344, EBI-712344;
CC       Q03393; O00560: SDCBP; NbExp=4; IntAct=EBI-712344, EBI-727004;
CC       Q03393; Q9P2Z0: THAP10; NbExp=3; IntAct=EBI-712344, EBI-745404;
CC   -!- PTM: Phosphorylation of Ser-19 is required for maximal enzyme activity.
CC       {ECO:0000269|PubMed:10531334}.
CC   -!- DISEASE: Hyperphenylalaninemia, BH4-deficient, A (HPABH4A)
CC       [MIM:261640]: An autosomal recessive disorder characterized by
CC       hyperphenylalaninemia, depletion of the neurotransmitters dopamine and
CC       serotonin, and progressive cognitive and motor deficits. Neurological
CC       symptoms are unresponsive to the classic phenylalanine-low diet.
CC       {ECO:0000269|PubMed:10220141, ECO:0000269|PubMed:10531334,
CC       ECO:0000269|PubMed:10585341, ECO:0000269|PubMed:10874306,
CC       ECO:0000269|PubMed:11388593, ECO:0000269|PubMed:7493990,
CC       ECO:0000269|PubMed:7698774, ECO:0000269|PubMed:8178819,
CC       ECO:0000269|PubMed:8707300, ECO:0000269|PubMed:9159737,
CC       ECO:0000269|PubMed:9222757, ECO:0000269|PubMed:9450907}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- MISCELLANEOUS: The active site is at the interface between 2 subunits.
CC       The proton acceptor Cys is on one subunit, and the charge relay system
CC       is on the other subunit.
CC   -!- SIMILARITY: Belongs to the PTPS family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M97655; AAA51541.1; -; mRNA.
DR   EMBL; D17400; BAA04224.1; -; mRNA.
DR   EMBL; D25234; BAA04959.1; -; Genomic_DNA.
DR   EMBL; L76259; AAB64229.1; -; Genomic_DNA.
DR   EMBL; U63383; AAC16970.1; -; Genomic_DNA.
DR   EMBL; U63380; AAC16970.1; JOINED; Genomic_DNA.
DR   EMBL; U63381; AAC16970.1; JOINED; Genomic_DNA.
DR   EMBL; U63382; AAC16970.1; JOINED; Genomic_DNA.
DR   EMBL; AB042297; BAA95486.1; -; Genomic_DNA.
DR   EMBL; EF445018; ACA06065.1; -; Genomic_DNA.
DR   EMBL; CH471065; EAW67195.1; -; Genomic_DNA.
DR   EMBL; BC009686; AAH09686.1; -; mRNA.
DR   EMBL; BC018029; AAH18029.1; -; mRNA.
DR   CCDS; CCDS8359.1; -.
DR   PIR; JC1405; JC1405.
DR   RefSeq; NP_000308.1; NM_000317.3.
DR   RefSeq; XP_054225538.1; XM_054369563.1.
DR   RefSeq; XP_054225539.1; XM_054369564.1.
DR   PDB; 3I2B; X-ray; 2.30 A; A/B/C/D/E/F/G/H/I/J/K/L=7-145.
DR   PDBsum; 3I2B; -.
DR   AlphaFoldDB; Q03393; -.
DR   SMR; Q03393; -.
DR   BioGRID; 111769; 51.
DR   FunCoup; Q03393; 1747.
DR   IntAct; Q03393; 28.
DR   MINT; Q03393; -.
DR   STRING; 9606.ENSP00000280362; -.
DR   BindingDB; Q03393; -.
DR   ChEMBL; CHEMBL4630823; -.
DR   DrugBank; DB03886; Biopterin.
DR   DrugBank; DB00688; Mycophenolate mofetil.
DR   iPTMnet; Q03393; -.
DR   PhosphoSitePlus; Q03393; -.
DR   BioMuta; PTS; -.
DR   jPOST; Q03393; -.
DR   MassIVE; Q03393; -.
DR   PaxDb; 9606-ENSP00000280362; -.
DR   PeptideAtlas; Q03393; -.
DR   ProteomicsDB; 58205; -.
DR   Pumba; Q03393; -.
DR   TopDownProteomics; Q03393; -.
DR   Antibodypedia; 780; 200 antibodies from 28 providers.
DR   DNASU; 5805; -.
DR   Ensembl; ENST00000280362.8; ENSP00000280362.3; ENSG00000150787.8.
DR   GeneID; 5805; -.
DR   KEGG; hsa:5805; -.
DR   MANE-Select; ENST00000280362.8; ENSP00000280362.3; NM_000317.3; NP_000308.1.
DR   UCSC; uc001pnj.5; human.
DR   AGR; HGNC:9689; -.
DR   CTD; 5805; -.
DR   DisGeNET; 5805; -.
DR   GeneCards; PTS; -.
DR   HGNC; HGNC:9689; PTS.
DR   HPA; ENSG00000150787; Low tissue specificity.
DR   MalaCards; PTS; -.
DR   MIM; 261640; phenotype.
DR   MIM; 612719; gene.
DR   OpenTargets; ENSG00000150787; -.
DR   Orphanet; 13; 6-pyruvoyl-tetrahydropterin synthase deficiency.
DR   VEuPathDB; HostDB:ENSG00000150787; -.
DR   eggNOG; KOG4105; Eukaryota.
DR   GeneTree; ENSGT00390000002752; -.
DR   HOGENOM; CLU_111016_2_0_1; -.
DR   InParanoid; Q03393; -.
DR   OMA; YETERNF; -.
DR   OrthoDB; 14045at2759; -.
DR   PAN-GO; Q03393; 1 GO annotation based on evolutionary models.
DR   PhylomeDB; Q03393; -.
DR   BioCyc; MetaCyc:HS07692-MONOMER; -.
DR   BRENDA; 4.2.3.12; 2681.
DR   PathwayCommons; Q03393; -.
DR   Reactome; R-HSA-1474151; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation.
DR   SABIO-RK; Q03393; -.
DR   SignaLink; Q03393; -.
DR   SIGNOR; Q03393; -.
DR   UniPathway; UPA00849; UER00819.
DR   BioGRID-ORCS; 5805; 12 hits in 1163 CRISPR screens.
DR   ChiTaRS; PTS; human.
DR   EvolutionaryTrace; Q03393; -.
DR   GeneWiki; PTS_(gene); -.
DR   GenomeRNAi; 5805; -.
DR   Pharos; Q03393; Tbio.
DR   PRO; PR:Q03393; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q03393; protein.
DR   Bgee; ENSG00000150787; Expressed in adrenal tissue and 208 other cell types or tissues.
DR   ExpressionAtlas; Q03393; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IDA:LIFEdb.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:LIFEdb.
DR   GO; GO:0003874; F:6-pyruvoyltetrahydropterin synthase activity; TAS:ProtInc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006520; P:amino acid metabolic process; TAS:ProtInc.
DR   GO; GO:0007417; P:central nervous system development; TAS:ProtInc.
DR   GO; GO:0006729; P:tetrahydrobiopterin biosynthetic process; TAS:ProtInc.
DR   CDD; cd00470; PTPS; 1.
DR   FunFam; 3.30.479.10:FF:000003; 6-pyruvoyl tetrahydrobiopterin synthase; 1.
DR   Gene3D; 3.30.479.10; 6-pyruvoyl tetrahydropterin synthase/QueD; 1.
DR   InterPro; IPR007115; 6-PTP_synth/QueD.
DR   InterPro; IPR038418; 6-PTP_synth/QueD_sf.
DR   InterPro; IPR022470; PTPS_Cys_AS.
DR   InterPro; IPR022469; PTPS_His_AS.
DR   NCBIfam; TIGR00039; 6PTHBS; 1.
DR   PANTHER; PTHR12589:SF7; 6-PYRUVOYL TETRAHYDROBIOPTERIN SYNTHASE; 1.
DR   PANTHER; PTHR12589; PYRUVOYL TETRAHYDROBIOPTERIN SYNTHASE; 1.
DR   Pfam; PF01242; PTPS; 1.
DR   PIRSF; PIRSF006113; PTP_synth; 1.
DR   SUPFAM; SSF55620; Tetrahydrobiopterin biosynthesis enzymes-like; 1.
DR   PROSITE; PS00987; PTPS_1; 1.
DR   PROSITE; PS00988; PTPS_2; 1.
DR   neXtProt; NX_Q03393; -.
DR   PharmGKB; PA34032; -.
DR   TreeFam; TF105796; -.
PE   1: Evidence at protein level;
KW   3D-structure; Disease variant; Lyase; Metal-binding; Phenylketonuria;
KW   Phosphoprotein; Proteomics identification; Reference proteome;
KW   Tetrahydrobiopterin biosynthesis; Zinc.
FT   CHAIN           1..145
FT                   /note="6-pyruvoyl tetrahydrobiopterin synthase"
FT                   /id="PRO_0000057914"
FT   ACT_SITE        43
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10123"
FT   ACT_SITE        90
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10124"
FT   ACT_SITE        134
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10124"
FT   BINDING         24
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10123"
FT   BINDING         49
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10123"
FT   BINDING         51
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10123"
FT   MOD_RES         19
FT                   /note="Phosphoserine; by PKG"
FT                   /evidence="ECO:0000269|PubMed:10531334,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         28
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1Z7"
FT   MOD_RES         128
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   VARIANT         16
FT                   /note="R -> C (in HPABH4A; severe decrease in activity;
FT                   diminishes phosphorylation by PKG; dbSNP:rs104894274)"
FT                   /evidence="ECO:0000269|PubMed:10531334,
FT                   ECO:0000269|PubMed:7493990, ECO:0000269|PubMed:8178819"
FT                   /id="VAR_006816"
FT   VARIANT         25
FT                   /note="R -> G (in HPABH4A; severe form;
FT                   dbSNP:rs1167104933)"
FT                   /evidence="ECO:0000269|PubMed:9450907"
FT                   /id="VAR_006817"
FT   VARIANT         25
FT                   /note="R -> Q (in HPABH4A; abolishes activity; no effect on
FT                   phosphorylation by PKG; dbSNP:rs104894273)"
FT                   /evidence="ECO:0000269|PubMed:10531334,
FT                   ECO:0000269|PubMed:7493990, ECO:0000269|PubMed:8178819"
FT                   /id="VAR_006818"
FT   VARIANT         26
FT                   /note="L -> F (in HPABH4A; dbSNP:rs1317230624)"
FT                   /evidence="ECO:0000269|PubMed:11388593"
FT                   /id="VAR_058265"
FT   VARIANT         35
FT                   /note="E -> G (in HPABH4A; dbSNP:rs1328320990)"
FT                   /id="VAR_006819"
FT   VARIANT         36
FT                   /note="N -> K (in HPABH4A; dbSNP:rs1449216377)"
FT                   /id="VAR_006820"
FT   VARIANT         47
FT                   /note="N -> D (in HPABH4A; transient phenotype due to
FT                   partial PTS deficiency; total loss of activity;
FT                   dbSNP:rs104894278)"
FT                   /evidence="ECO:0000269|PubMed:10220141"
FT                   /id="VAR_008040"
FT   VARIANT         52
FT                   /note="N -> S (in HPABH4A; severe form; dbSNP:rs104894275)"
FT                   /evidence="ECO:0000269|PubMed:8707300,
FT                   ECO:0000269|PubMed:9450907"
FT                   /id="VAR_006821"
FT   VARIANT         56
FT                   /note="V -> M (in HPABH4A; mild form; dbSNP:rs104894277)"
FT                   /evidence="ECO:0000269|PubMed:9450907"
FT                   /id="VAR_006822"
FT   VARIANT         57
FT                   /note="Missing (in HPABH4A; dbSNP:rs770387277)"
FT                   /evidence="ECO:0000269|PubMed:10585341,
FT                   ECO:0000269|PubMed:7493990, ECO:0000269|PubMed:9222757"
FT                   /id="VAR_006823"
FT   VARIANT         67
FT                   /note="T -> M (in HPABH4A; dbSNP:rs370340361)"
FT                   /evidence="ECO:0000269|PubMed:11388593,
FT                   ECO:0000269|PubMed:9222757"
FT                   /id="VAR_006824"
FT   VARIANT         70
FT                   /note="V -> D (in HPABH4A; dbSNP:rs1592880489)"
FT                   /evidence="ECO:0000269|PubMed:9450907"
FT                   /id="VAR_006825"
FT   VARIANT         87
FT                   /note="P -> L (in HPABH4A; dbSNP:rs765406631)"
FT                   /evidence="ECO:0000269|PubMed:11388593,
FT                   ECO:0000269|PubMed:7493990"
FT                   /id="VAR_006826"
FT   VARIANT         87
FT                   /note="P -> S (in HPABH4A; severe form; dbSNP:rs104894276)"
FT                   /evidence="ECO:0000269|PubMed:8707300,
FT                   ECO:0000269|PubMed:9450907"
FT                   /id="VAR_006827"
FT   VARIANT         96
FT                   /note="D -> N (in HPABH4A; severe form; dbSNP:rs104894280)"
FT                   /evidence="ECO:0000269|PubMed:9450907"
FT                   /id="VAR_006828"
FT   VARIANT         97
FT                   /note="V -> M (in HPABH4A; dbSNP:rs750455879)"
FT                   /evidence="ECO:0000269|PubMed:10585341"
FT                   /id="VAR_058266"
FT   VARIANT         99
FT                   /note="Y -> C (in HPABH4A; dbSNP:rs1555198458)"
FT                   /evidence="ECO:0000269|PubMed:10874306"
FT                   /id="VAR_058267"
FT   VARIANT         100
FT                   /note="F -> V (in HPABH4A; dbSNP:rs2135410321)"
FT                   /id="VAR_006829"
FT   VARIANT         106
FT                   /note="T -> M (in HPABH4A; dbSNP:rs200712908)"
FT                   /evidence="ECO:0000269|PubMed:9450907"
FT                   /id="VAR_006830"
FT   VARIANT         114
FT                   /note="I -> V (in HPABH4A; dbSNP:rs1555198495)"
FT                   /evidence="ECO:0000269|PubMed:7698774,
FT                   ECO:0000269|PubMed:9159737"
FT                   /id="VAR_006831"
FT   VARIANT         116
FT                   /note="D -> G (in HPABH4A; transient phenotype due to
FT                   partial PTS deficiency; mild decrease of activity;
FT                   dbSNP:rs104894279)"
FT                   /evidence="ECO:0000269|PubMed:10220141"
FT                   /id="VAR_008041"
FT   VARIANT         124
FT                   /note="V -> L (in HPABH4A; dbSNP:rs150726932)"
FT                   /evidence="ECO:0000269|PubMed:11388593"
FT                   /id="VAR_058268"
FT   VARIANT         129
FT                   /note="K -> E (in HPABH4A; dbSNP:rs1040441824)"
FT                   /evidence="ECO:0000269|PubMed:9222757"
FT                   /id="VAR_006832"
FT   VARIANT         136
FT                   /note="D -> G (in HPABH4A; dbSNP:rs1859972447)"
FT                   /evidence="ECO:0000269|PubMed:11388593"
FT                   /id="VAR_058269"
FT   VARIANT         136
FT                   /note="D -> V (in HPABH4A; dbSNP:rs1859972447)"
FT                   /evidence="ECO:0000269|PubMed:11388593,
FT                   ECO:0000269|PubMed:9222757"
FT                   /id="VAR_006833"
FT   MUTAGEN         19
FT                   /note="S->A: Decrease in activity; abolishes
FT                   phosphorylation by PKG."
FT                   /evidence="ECO:0000269|PubMed:10531334"
FT   CONFLICT        114
FT                   /note="I -> M (in Ref. 9; AAH18029)"
FT                   /evidence="ECO:0000305"
FT   STRAND          11..24
FT                   /evidence="ECO:0007829|PDB:3I2B"
FT   STRAND          29..31
FT                   /evidence="ECO:0007829|PDB:3I2B"
FT   HELIX           33..40
FT                   /evidence="ECO:0007829|PDB:3I2B"
FT   HELIX           41..44
FT                   /evidence="ECO:0007829|PDB:3I2B"
FT   STRAND          49..62
FT                   /evidence="ECO:0007829|PDB:3I2B"
FT   TURN            65..67
FT                   /evidence="ECO:0007829|PDB:3I2B"
FT   HELIX           73..83
FT                   /evidence="ECO:0007829|PDB:3I2B"
FT   HELIX           85..88
FT                   /evidence="ECO:0007829|PDB:3I2B"
FT   HELIX           93..96
FT                   /evidence="ECO:0007829|PDB:3I2B"
FT   HELIX           98..101
FT                   /evidence="ECO:0007829|PDB:3I2B"
FT   HELIX           107..119
FT                   /evidence="ECO:0007829|PDB:3I2B"
FT   STRAND          127..135
FT                   /evidence="ECO:0007829|PDB:3I2B"
FT   STRAND          138..142
FT                   /evidence="ECO:0007829|PDB:3I2B"
SQ   SEQUENCE   145 AA;  16386 MW;  A1CD0DC2F83187E0 CRC64;
     MSTEGGGRRC QAQVSRRISF SASHRLYSKF LSDEENLKLF GKCNNPNGHG HNYKVVVTVH
     GEIDPATGMV MNLADLKKYM EEAIMQPLDH KNLDMDVPYF ADVVSTTENV AVYIWDNLQK
     VLPVGVLYKV KVYETDNNIV VYKGE
//
